Tang et al listed risk factors associated with hyperkalemia in a patient treated with a drug that inhibits the renin-angiotensin-aldosterone system such as an aldosterone receptor antagonist. A patient with one or more of these risk factors should be monitored for hyperkalemia during therapy with one of these agents.

To read more or access our algorithms and calculators, please log in or register.